Main Menu

On September 28, Delaware Superior Court Judge Paul R. Wallace ruled that Pfizer is entitled to coverage under its directors and officers policy with U.S. Specialty. The insurer will cover the “costs to defend and settle multidistrict litigation that accused the company of misleading investors about the alleged cardiovascular risks of its pain treatments Celebrex and Bextra.” Pfizer is represented by McKool Smith principals Robin CohenAdam Ziffer, and Marc Ladd. For more details, read the entire article here.

Practice Areas

Back to Page